Clinical Characteristics at Initial Presentation and Impact of Dual Therapy on the Outcome of BacteremicStreptococcus pneumoniaePneumonia in Adults | Zendy

Karl Heinz Weiss | Zendy; Donald E. Low | Zendy; L Cortés | Zendy; A Beaupré | Zendy; Robert Gauthier | Zendy; Pascal Grégoire | Zendy; Martin Legaré | Zendy; F Neoveu | Zendy; D Thibert | Zendy; Cécile Tremblay | Zendy

Open Access

Clinical Characteristics at Initial Presentation and Impact of Dual Therapy on the Outcome of BacteremicStreptococcus pneumoniaePneumonia in Adults

Author(s) -

Karl Heinz Weiss,

Donald E. Low,

L Cortés,

A Beaupré,

Robert Gauthier,

Pascal Grégoire,

Martin Legaré,

F Neoveu,

D Thibert,

Cécile Tremblay

Publication year - 2004

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2004/461392

Subject(s) - medicine , pneumonia , azithromycin , streptococcus pneumoniae , community acquired pneumonia , pneumonia severity index , regimen , ceftriaxone , cohort , antibiotics , microbiology and biotechnology , biology

Approximately 10% of patients hospitalized with community-acquired pneumonia (CAP) are bacteremic. Bacteremic Streptococcus pneumoniae pneumonia (BSPP) is the number one cause of mortality, representing up to 70% of all CAP deaths. In fact, all CAP guidelines have identified this issue as one of the most important issues when establishing their recommendations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research